Cell-mediated responses of immunized vervet monkeys to defined Leishmania T-cell epitopes
- PMID: 7513306
- PMCID: PMC186396
- DOI: 10.1128/iai.62.5.1733-1741.1994
Cell-mediated responses of immunized vervet monkeys to defined Leishmania T-cell epitopes
Abstract
A population of vervet monkeys was immunized with killed parasites and infected with Leishmania major promastigotes either by needle or by infected-fly bite. The responses of recovered monkeys to mitogens, killed parasites, and molecularly defined T-cell epitopes were then compared with those of control animals. Peripheral blood mononuclear cells (PBMC) from both naive and recovered animals proliferated strongly in response to both B- and T-cell mitogens, although the responses of the recovered animals were less strong than those of the naive animals. Cells from recovered vervets, but not those from naive vervets, also proliferated in response to parasite antigens and synthetic T-cell epitopes. Likewise, cells from recovered animals released gamma interferon and either interleukin 2 (IL-2) or IL-4 into culture media in response to both of the above-mentioned antigens, whereas cells from control animals did not. The fact that no IL-5 could be measured following parasite antigen or synthetic T-cell epitope stimulation of PBMC suggested that cells proliferating in response to these molecules belonged to the Th1 subset. Phenotypic analysis of the PBMC showed a marked increase in T-cell but not B-cell populations in recovered animals. Among this population was an increased number of CD45R0+ memory cells. The data from this study are in keeping with the earlier finding that vervet monkeys provide an excellent model system for leishmaniasis. Further, these data support the contention that synthetic T-cell epitopes are prime candidates for molecularly defined Leishmania vaccines.
Similar articles
-
Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis.Infect Immun. 1998 Jul;66(7):3100-5. doi: 10.1128/IAI.66.7.3100-3105.1998. Infect Immun. 1998. PMID: 9632572 Free PMC article.
-
Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis.Am J Trop Med Hyg. 1995 Aug;53(2):195-201. doi: 10.4269/ajtmh.1995.53.195. Am J Trop Med Hyg. 1995. PMID: 7677224
-
Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection.Infect Immun. 2001 Jan;69(1):245-51. doi: 10.1128/IAI.69.1.245-251.2001. Infect Immun. 2001. PMID: 11119512 Free PMC article.
-
Differences in immune responses against Leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery.Parasit Vectors. 2016 Sep 6;9(1):492. doi: 10.1186/s13071-016-1777-x. Parasit Vectors. 2016. PMID: 27600664 Free PMC article. Review.
-
The in vitro generation and functional analysis of murine T cell populations and clones specific for a protozoan parasite, Leishmania tropica.Immunol Rev. 1982;61:215-43. doi: 10.1111/j.1600-065x.1982.tb00378.x. Immunol Rev. 1982. PMID: 6174412 Review. No abstract available.
Cited by
-
Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.PLoS One. 2009 Dec 2;4(12):e7880. doi: 10.1371/journal.pone.0007880. PLoS One. 2009. PMID: 19956549 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases